Published

BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: The international journal of neuropsychopharmacology
Date: 2025-02-01
Source: Europe PMC
DOI: Unavailable
PubMed: Unavailable

Authors

*Leonard Lerer Katherine Spear Jeet Varia Cecily Keim Alex Buko Karin Blakolmer Bernard Lerer

Watch author

Derived topics and classifications

psilocybin Depression Metabolomics Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2026-01-01 Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2025-01-01 Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator AdministrationbioRxiv · 2024-11-28 Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.Molecular psychiatry · 2024-07-01 Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.Molecular psychiatry · 2024-01-01 Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom ExtractResearch Square · 2023-07-20 Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders.Neuroscience Applied · 2023-01-01 Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.Frontiers in psychiatry · 2022-01-01